HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $587K of Halozyme Therapeutics, Inc.
Sold$586,675
$58.67Price
10,000Shares
−6%Stake
What HALO did after the filing
- The stock from Tue, Dec 13 close, $58.94
- −14.0%
- S&P 500, same days
- +1.4%
Measured over 30 trading days, to the Jan 27 close.
Traded Tue, Dec 13. Filed Tue, Dec 13, 1:09 PM ET, during the session. Returns use the Dec 13 close and the Jan 27 close. Not investment advice.